These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

827 related items for PubMed ID: 26436161

  • 1. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [Abstract] [Full Text] [Related]

  • 2. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR, European Vasculitis Society (EUVAS).
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
    Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ding L, Iklé D, Villareal M, Lim N, Brunetta P, Fervenza FC, Monach PA, Stone JH, Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.
    Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
    [Abstract] [Full Text] [Related]

  • 4. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
    de Menthon M, Cohen P, Pagnoux C, Buchler M, Sibilia J, Détrée F, Gayraud M, Khellaf M, Penalba C, Legallicier B, Mouthon L, Guillevin L.
    Clin Exp Rheumatol; 2011 Jun; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of ANCA-associated vascularitides].
    Guillevin L, Pagnoux C.
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.
    Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Iklé D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH, Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.
    Arthritis Rheum; 2013 Sep; 65(9):2441-9. PubMed ID: 23754238
    [Abstract] [Full Text] [Related]

  • 7. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL, Puéchal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L, French Vasculitis Study Group.
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [Abstract] [Full Text] [Related]

  • 8. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
    Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quémeneur T, Blanchard-Delaunay C, Godmer P, Puéchal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L, French Vasculitis Study Group.
    N Engl J Med; 2014 Nov 06; 371(19):1771-80. PubMed ID: 25372085
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.
    PLoS One; 2017 Nov 06; 12(10):e0185880. PubMed ID: 29016646
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study Group.
    N Engl J Med; 2008 Dec 25; 359(26):2790-803. PubMed ID: 19109574
    [Abstract] [Full Text] [Related]

  • 14. Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
    Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group.
    N Engl J Med; 2010 Jul 15; 363(3):221-32. PubMed ID: 20647199
    [Abstract] [Full Text] [Related]

  • 15. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, Fujimoto S, Muso E, Murakawa Y, Arimura Y, Makino H, Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan.
    Arthritis Res Ther; 2015 Nov 02; 17():305. PubMed ID: 26525413
    [Abstract] [Full Text] [Related]

  • 16. Treatment of granulomatosis with polyangiitis (Wegener's).
    Pagnoux C, Guillevin L.
    Expert Rev Clin Immunol; 2015 Mar 02; 11(3):339-48. PubMed ID: 25644677
    [Abstract] [Full Text] [Related]

  • 17. Lower doses of rituximab in remission induction for refractory granulomatosis with polyangiitis.
    Wawrzycka-Adamczyk K, Zugaj A, Włudarczyk A, Kosałka J, Sznajd J, Bazan-Socha S, Musiał J.
    Przegl Lek; 2014 Mar 02; 71(12):663-5. PubMed ID: 25951692
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.
    Puéchal X, Pagnoux C, Perrodeau É, Hamidou M, Boffa JJ, Kyndt X, Lifermann F, Papo T, Merrien D, Smail A, Delaval P, Hanrotel-Saliou C, Imbert B, Khouatra C, Lambert M, Leské C, Ly KH, Pertuiset E, Roblot P, Ruivard M, Subra JF, Viallard JF, Terrier B, Cohen P, Mouthon L, Le Jeunne C, Ravaud P, Guillevin L, French Vasculitis Study Group.
    Arthritis Rheumatol; 2016 Mar 02; 68(3):690-701. PubMed ID: 26473755
    [Abstract] [Full Text] [Related]

  • 19. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L, Springer J, Langford CA, Hoffman GS.
    Arthritis Rheumatol; 2014 Oct 02; 66(10):2862-70. PubMed ID: 24943239
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.